Furthermore, loading siRNA targeting HuR into folic acid (FA)-coupled polyamide-amine dendrimer (Den)-based nanoparticles revealed that the formulation was effective in reducing HuR expression and cell proliferation in lung cancer cells. Here, ELAVL1 is linked to lung cancer.